A medicine’s side effect, even where the product has been duly approved, does not always give rise to a duty to compensate; understand the criteria the courts have been applying.
Side effects of medicines have become a frequent subject before the Brazilian courts. More and more consumers report adverse reactions after taking a medicine holding a regular health registration. They then claim compensation from the laboratory that manufactured it. The legal answer, however, is not automatic. Having taken the medicine and felt unwell is not, in itself, enough to give rise to a duty to compensate.
What has changed in the debate on side effects of medicines
For a long time, claims of this kind were rare. Today their number is growing and the courts need to establish clearer criteria. As a result, the discussion is no longer merely emotional and now requires technical analysis.
The central issue is the distinction between inherent risk and defect in the product. Every medicine carries known risks. Accordingly, the package insert sets out possible reactions, their estimated frequency and the contraindications. Where the consumer suffers a reaction that was already foreseen and disclosed, as a rule there is no defect.
Conversely, the position changes where the product displays a manufacturing flaw, contamination or an incorrect dosage. It also changes where the package insert omits a material risk or provides insufficient information. In such cases, the Código de Defesa do Consumidor (Brazilian Consumer Protection Code) points to the manufacturer’s liability for the product itself.
In addition, regulatory approval carries weight in the analysis. Health registration indicates that the medicine has undergone a safety and efficacy assessment. It does not, however, operate as an absolute shield. The laboratory remains under a duty to monitor effects and to update the information provided to the public.
Who is affected by an adverse reaction to a medicine
First of all, consumers. They need to understand that compensation depends on proof of the defect and of the causal link with the damage. In other words, it is not enough to demonstrate the use of the medicine and the health problem.
Laboratories also feel the impact. For them, the defence turns on the quality of the information in the package insert, on manufacturing controls and on pharmacovigilance. Likewise, it is important to retain batch records and records of communications with the health authority.
Physicians, pharmacies and distributors feature in some claims. In general, primary liability falls on the manufacturer. Nevertheless, off-label prescription or inadequate guidance may shift part of the debate towards other parties.
What to do now when faced with a medicine’s side effect
Anyone who has suffered an adverse reaction should organise the evidence from the outset. In practice, certain precautions make a difference:
- Keep the packaging, the batch number and the product’s invoice.
- Gather medical records, test results and reports linking the reaction to the use of the medicine.
- Check whether the package insert disclosed that effect and in what degree of detail.
- Report the event through the health authority’s notification channel.
For companies in the sector, the moment calls for a review of information processes. First, the package insert must reflect the most recent safety data. Next, customer service channels must record complaints and forward them to pharmacovigilance. Lastly, it is advisable to document each stage, since technical evidence usually decides disputes of this kind.
In short, a laboratory’s liability for a medicine’s side effect requires a case-by-case analysis, focusing on the information provided and on whether a defect genuinely exists. See also other legal news commented on by the firm.